The current stock price of AKAN is 0.4701 USD. In the past month the price decreased by -43.56%. In the past year, price decreased by -90.36%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 49.35 | 1.03T | ||
| JNJ | JOHNSON & JOHNSON | 19.82 | 495.71B | ||
| MRK | MERCK & CO. INC. | 12.6 | 275.48B | ||
| PFE | PFIZER INC | 7.9 | 143.79B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.52 | 113.80B | ||
| ZTS | ZOETIS INC | 20.01 | 55.90B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.8 | 23.24B | ||
| VTRS | VIATRIS INC | 5.41 | 14.51B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.21 | 11.55B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.45B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.72B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 5.05B |
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
AKANDA CORP
1A, 1B Learoyd Road
New Romney GB
Employees: 5
Phone: 442034889514
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
The current stock price of AKAN is 0.4701 USD. The price decreased by -14.81% in the last trading session.
AKAN does not pay a dividend.
AKAN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
AKAN stock is listed on the Nasdaq exchange.
AKANDA CORP (AKAN) operates in the Health Care sector and the Pharmaceuticals industry.
AKANDA CORP (AKAN) currently has 5 employees.
ChartMill assigns a fundamental rating of 1 / 10 to AKAN. AKAN has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AKAN reported a non-GAAP Earnings per Share(EPS) of -12.28. The EPS increased by 99.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.76% | ||
| ROE | -95.78% | ||
| Debt/Equity | 0.08 |